ストックスクリーナーアプリを入手
0.0002
0.00%
0.00
Effector Therapeutics Inc (EFTR) 最新ニュース
Indian American Premal Patel joins Elephas Biosciences as CMO - The American Bazaar
Non-covid mRNA Vaccine and Therapeutics Market Exclusive Report on the Latest Revenue and Future Scope - openPR.com
Barclays Forecasts Strong Price Appreciation for Lloyds Banking Group (LON:LLOY) Stock - Defense World
Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Head to Head Analysis: Hepion Pharmaceuticals (NASDAQ:HEPA) versus eFFECTOR Therapeutics (NASDAQ:EFTR) - Defense World
Is eFFECTOR Therapeutics Inc. (LWK) stock undervalued at current price2025 Historical Comparison & Capital Protection Trade Alerts - Улправда
Is eFFECTOR Therapeutics Inc. (LWK) stock expanding market penetrationTrade Analysis Summary & High Yield Stock Recommendations - Улправда
ELEPHAS BIOSCIENCES STRENGTHENS SCIENTIFIC AND CLINICAL LEADERSHIP AS COMPANY ADVANCES TOWARD COMMERCIAL AVAILABILITY OF ITS LIVE-TUMOR IMMUNOLOGY PLATFORM - morningstar.com
WeRide (NASDAQ:WRD) Now Covered by Analysts at CLSA - Defense World
PowerFleet (NASDAQ:AIOT) Given Outperform Rating at Barrington Research - Defense World
Big Rock Brewery (TSE:BR) Shares Cross Below 50 Day Moving Average – What’s Next? - Defense World
eFFECTOR Therapeutics (NASDAQ:EFTR) and Synaptogenix (NASDAQ:TAOX) Head to Head Review - Defense World
Can eFFECTOR Therapeutics Inc. (LWK) stock expand revenue streamsTrade Entry Report & Weekly Watchlist for Consistent Profits - Улправда
Is eFFECTOR Therapeutics Inc. (LWK) stock vulnerable to rate hikesTrade Volume Report & Stock Market Timing Techniques - DonanımHaber
PD-1 and PD-L1 Inhibitors Market expected to Witness Huge Revenue Growth to 2034 - openPR.com
Why eFFECTOR Therapeutics Inc. (LWK) stock gets analyst attentionInsider Buying & AI Enhanced Trading Signals - Newser
Is eFFECTOR Therapeutics Inc. (LWK) stock positioned for secular growth2025 Market Outlook & Long Hold Capital Preservation Tips - Newser
Why eFFECTOR Therapeutics Inc. (LWK) stock remains top ratedWeekly Stock Recap & Daily Profit Maximizing Tips - Newser
Is eFFECTOR Therapeutics Inc. (LWK) stock resilient in recession scenariosMarket Performance Summary & Risk Controlled Swing Alerts - Newser
Why eFFECTOR Therapeutics Inc. (LWK) stock is listed among top recommendations2025 Technical Patterns & Risk Managed Investment Signals - Newser
What consensus target says about eFFECTOR Therapeutics Inc. (LWK) stockJuly 2025 WrapUp & Real-Time Volume Trigger Notifications - Newser
How dovish Fed policy supports eFFECTOR Therapeutics Inc. (LWK) stockJuly 2025 Sector Moves & Stock Portfolio Risk Management - Newser
eFFECTOR Therapeutics, Inc. (EFTR) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
eFFECTOR Therapeutics, Inc. (EFTR) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
How eFFECTOR Therapeutics Inc. (LWK) stock gains from tech spending2025 Short Interest & Fast Gaining Stock Reports - newser.com
Wall Street indexes jump as bets on rate cut increase, Nvidia gains on report - marketscreener.com
eFFECTOR Therapeutics (NASDAQ:EFTR) versus Evotec (OTCMKTS:EVTCY) Head to Head Review - Defense World
Major corporations shift listings to Nasdaq amid growing tech focus - marketscreener.com
Why eFFECTOR Therapeutics Inc. (LWK) stock attracts wealthy investorsAnalyst Downgrade & Safe Capital Preservation Plans - newser.com
Will eFFECTOR Therapeutics Inc. (LWK) stock justify high valuationJuly 2025 Weekly Recap & Technical Pattern Based Buy Signals - newser.com
4.73%
0.92%
大文字化:
|
ボリューム (24 時間):